Desonide sodium phosphateAlternative Names: Desonide; Prenacid
Latest Information Update: 28 Sep 2016
At a glance
- Originator SIFI
- Developer NovaMedica; SIFI
- Class Anti-inflammatories; Glucocorticoids; Pregnadienetriols; Small molecules
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Ocular inflammation
Most Recent Events
- 28 Sep 2016 Chemical structure information added